Literature DB >> 19700010

Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues.

Jo-David Fine1, Jemima E Mellerio.   

Abstract

Based upon case reports and small case series, it has been known for many years that some types and subtypes of inherited epidermolysis bullosa (EB) may be at risk for developing one or more extracutaneous complications. Many of these are associated with considerable morbidity; some may result in death. Only over the past few years have there been data generated from large, well characterized cohorts. However, these data, to date, have been published almost exclusively in the nondermatologic literature. Our objective is to provide dermatologists with a comprehensive review of each major extracutaneous complication with a summary of the pertinent literature and recommendations for evaluation and optimal management. Part I highlights epithelial associated tissues, and part II addresses other organs. Based on these reviews, the readership should gain a greater understanding of the types of complications that may occur, when they are most likely to develop, and the range of medical and surgical interventions that are currently available. It should also be possible for the reader to develop surveillance strategies based on an understanding of the published evidence-based data. The breadth and range of severity of complications that arise in some EB types and subtypes within the external eye, ear, nose, upper airway, and gastrointestinal and genitourinary tracts suggest that optimal management must be multidisciplinary. Given the unique knowledge that dermatologists have of this disease, we believe that the care of the EB patient should be under the direction of his or her dermatologist, who can best assist in timely referrals to those specialists who are most experienced in the care of specific extracutaneous problems.

Entities:  

Mesh:

Year:  2009        PMID: 19700010     DOI: 10.1016/j.jaad.2009.03.052

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  57 in total

1.  BPAG1-e restricts keratinocyte migration through control of adhesion stability.

Authors:  Magdalene Michael; Rumena Begum; Kenneth Fong; Celine Pourreyrone; Andrew P South; John A McGrath; Maddy Parsons
Journal:  J Invest Dermatol       Date:  2013-09-11       Impact factor: 8.551

Review 2.  The collagenopathies: review of clinical phenotypes and molecular correlations.

Authors:  Rebekah Jobling; Rohan D'Souza; Naomi Baker; Irene Lara-Corrales; Roberto Mendoza-Londono; Lucie Dupuis; Ravi Savarirayan; L Ala-Kokko; Peter Kannu
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

Review 3.  Anaesthetic management of children with epidermolysis bullosa.

Authors:  L Bowen; M T Burtonwood
Journal:  BJA Educ       Date:  2017-11-28

4.  A consensus approach to wound care in epidermolysis bullosa.

Authors:  Elena Pope; Irene Lara-Corrales; Jemima Mellerio; Anna Martinez; Gregory Schultz; Robert Burrell; Laurie Goodman; Patricia Coutts; John Wagner; Upton Allen; Gary Sibbald
Journal:  J Am Acad Dermatol       Date:  2012-03-02       Impact factor: 11.527

Review 5.  [Mucosal manifestations of epidermolysis bullosa : Clinical presentation and management].

Authors:  C Prodinger; A Diem; J W Bauer; M Laimer
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

6.  Dental and Anaesthetic Challenges in a Patient with Dystrophic Epidermolysis Bullosa.

Authors:  Ali Al-Abadi; Salah A Al-Azri; Abdulaziz Bakathir; Yusra Al-Riyami
Journal:  Sultan Qaboos Univ Med J       Date:  2016-11-30

7.  Rare case of dysphagia, skin blistering, missing nails in a young boy.

Authors:  Jasbir Makker; Bharat Bajantri; Prospere Remy
Journal:  World J Gastrointest Endosc       Date:  2015-02-16

8.  Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa.

Authors:  G Rodari; S Guez; F Manzoni; K K Chalouhi; E Profka; S Bergamaschi; S Salera; G Tadini; F M Ulivieri; A Spada; C Giavoli; S Esposito
Journal:  Osteoporos Int       Date:  2016-12-23       Impact factor: 4.507

9.  Oral viscous budesonide as a first-line approach to esophageal stenosis in epidermolysis bullosa: an open-label trial in six children.

Authors:  Andrea Zanini; Sophie Guez; Simona Salera; Giorgio Farris; Anna Morandi; Valerio Gentilino; Ernesto Leva; Francesca Manzoni; Maria Angela Pavesi; Susanna Esposito; Francesco Macchini
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

Review 10.  Inherited epidermolysis bullosa.

Authors:  Jo-David Fine
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.